In a 31-year-old man with a recent upper respiratory infection, what are the likely causes of pericarditis and how should acute pericarditis and suspected myocarditis be managed?

Causes of Pericarditis in a Young Adult Post-URI

In a 31-year-old man with recent upper respiratory infection, viral infection is the most likely cause of pericarditis, followed by idiopathic (presumed immune-mediated) etiology. 1

Etiology

Viral infections are the most common identifiable cause of acute pericarditis in developed countries, particularly following upper respiratory illness. 1 The clinical scenario described—a young adult with recent URI—fits the classic presentation where:

• Cardiotropic viruses cause pericardial inflammation through direct cytolytic effects and/or immune-mediated mechanisms
• Myopericarditis manifestations are frequently preceded by or concurrent with acute respiratory illness (especially acute tonsillitis, pneumonia) or gastroenteritis 1
• In up to 20% of cases with detailed virological studies, viral etiology is confirmed 1

Idiopathic pericarditis (presumed immune-mediated) accounts for most cases where specific etiology cannot be identified, which is common in immunocompetent patients in developed countries. 1

Other Causes to Consider:

• Tuberculosis: Most common cause in endemic areas and developing countries 1, 2
• Bacterial: Rare in post-antibiotic era but can occur (e.g., H. influenzae following sinusitis) 3
• Post-procedural/iatrogenic: Following cardiac procedures 2
• Autoimmune diseases: Connective tissue diseases, inflammatory bowel disease 1
• Drug-induced or post-radiation 1

---

Management of Acute Pericarditis

First-line therapy is aspirin (750-1000 mg every 8 hours) or NSAIDs (ibuprofen 600 mg every 8 hours) PLUS colchicine (0.5 mg once daily if <70 kg, or 0.5 mg twice daily if ≥70 kg), with gastroprotection. 1

Treatment Algorithm

Initial Therapy (Class I, Level A recommendations):

1. NSAIDs/Aspirin for 1-2 weeks 1

   • Aspirin: 750-1000 mg every 8 hours
   • OR Ibuprofen: 600 mg every 8 hours
   • Always provide gastroprotection

2. Colchicine for 3 months 1

   • 0.5 mg once daily (<70 kg) or twice daily (≥70 kg)
   • Halves the recurrence rate (from 15-30% to <10%)
   • Tapering not mandatory, but can use 0.5 mg every other day in final weeks

3. Monitor with CRP to guide treatment duration and assess response 1

   • Continue therapy until symptom resolution AND CRP normalization
   • Reassess after 1 week 1

4. Taper NSAIDs/Aspirin gradually 1

   • Decrease aspirin by 250-500 mg every 1-2 weeks
   • Decrease ibuprofen by 200-400 mg every 1-2 weeks

Exercise Restriction:

• Non-athletes: Until symptom resolution and normalization of CRP, ECG, and echocardiogram 1
• Athletes: Minimum 3 months restriction until complete normalization 1

When to Avoid Corticosteroids:

Corticosteroids are NOT recommended as first-line therapy (Class III recommendation) 1 because they:

• Favor chronic evolution of disease
• Promote drug dependence
• Increase recurrence rates up to 50% 1

Second-Line Therapy:

Low-dose corticosteroids (prednisone 0.2-0.5 mg/kg/day) should only be considered when: 1

• Contraindication to aspirin/NSAIDs AND colchicine
• Failure of first-line therapy
• Infectious cause has been excluded
• Specific indication exists (e.g., autoimmune disease)

If used: Maintain initial dose until symptom resolution and CRP normalization, then taper gradually 1

---

Management of Myopericarditis

Myopericarditis (pericarditis with myocardial involvement) is managed identically to acute pericarditis with NSAIDs/aspirin plus colchicine, but requires additional monitoring for ventricular dysfunction and arrhythmias. 1

Diagnostic Criteria:

Myopericarditis is diagnosed when patients meet criteria for acute pericarditis PLUS:

• Elevated troponin I/T or CK-MB 1
• WITHOUT new focal or diffuse LV dysfunction on echo or CMR 1

(If LV dysfunction is present, this is "perimyocarditis"—predominantly myocarditis with pericardial involvement)

Treatment Approach:

1. Same anti-inflammatory regimen as acute pericarditis 1

   • NSAIDs/aspirin + colchicine
   • Same dosing and duration

2. Additional monitoring for:

   • Ventricular function (echocardiography)
   • Arrhythmias
   • Heart failure symptoms

3. Exercise restriction is critical 1

   • Especially important given myocardial involvement
   • Athletes: Minimum 3 months until complete normalization

Prognosis Considerations:

• Viral/idiopathic pericarditis: Generally excellent prognosis 1
  • Constrictive pericarditis risk <1%
  • Cardiac tamponade rare
• Myopericarditis: Troponin elevation does NOT worsen prognosis if LV function is preserved 1
• Recurrence risk: 15-30% without colchicine, reduced to <10% with colchicine 1

---

Key Clinical Pitfalls:

⚠️ Do NOT use high-dose corticosteroids as first-line therapy—this dramatically increases recurrence rates 1

⚠️ Do NOT stop treatment based on symptom resolution alone—continue until CRP normalizes to prevent recurrence 1

⚠️ Do NOT allow premature return to exercise—this can precipitate complications, especially in myopericarditis 1

⚠️ Do NOT forget gastroprotection with NSAIDs/aspirin 1

⚠️ Do NOT undertake extensive etiologic workup in low-risk patients—it is not mandatory in countries with low TB prevalence, given the benign course and low diagnostic yield 1, 2